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Abstract
Background: In 2010, the iPrEx trial demonstrated that oral antiretroviral pre-exposure prophylaxis (PrEP) reduced the risk of
HIV acquisition among high-risk men who have sex with men (MSM). The impact of iPrEx on PrEP knowledge and actual use
among at-risk MSM is unknown. Online surveys were conducted to assess PrEP awareness, interest and experience among
at-risk MSM before and after iPrEx, and to determine demographic and behavioral factors associated with these measures.
Methods and Findings: Cross-sectional, national, internet-based surveys were administered to U.S. based members of the
most popular American MSM social networking site 2 months before (n=398) and 1 month after (n=4 558) publication of
iPrEx results. Comparisons were made between these samples with regards to PrEP knowledge, interest, and experience.
Data were collected on demographics, sexual risk, and experience with post-exposure prophylaxis (PEP). Regression
analyses were performed to identify factors associated with PrEP awareness, interest, and experience post-iPrEx. Most
participants were white, educated, and indicated high-risk sexual behaviors. Awareness of PrEP was limited pre- and post-
iPrEx (13% vs. 19%), whereas interest levels after being provided with a description of PrEP remained high (76% vs. 79%).
PrEP use remained uncommon (0.7% vs. 0.9%). PrEP use was associated with PEP awareness (OR 7.46; CI 1.52–36.6) and PEP
experience (OR 34.2; CI 13.3–88.4). PrEP interest was associated with older age (OR 1.01; CI 1.00–1.02), unprotected anal
intercourse with $1 male partner in the prior 3 months (OR 1.40; CI 1.10–1.77), and perceiving oneself at increased risk for
HIV acquisition (OR 1.20; CI 1.13–1.27).
Conclusions: Among MSM engaged in online networking, awareness of PrEP was limited 1 month after the iPrEx data were
released. Utilization was low, although some MSM who reported high-risk behaviors were interested in using PrEP. Studies
are needed to understand barriers to PrEP utilization by at-risk MSM.
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Introduction
As 61% of new HIV infections in the United States occur among
men who have sex with men (MSM) [1], new prevention strategies
are urgently needed in this population. In November 2010, the
iPrEx study demonstrated that oral antiretroviral pre-exposure
chemoprophylaxis (PrEP)witha once-daily tablet containinga fixed
dose combination of tenofovir disoproxil fumarate and emtricita-
bine (FTC-TDF) reduced the risk of HIV acquisition among at-risk
MSM and transgendered women compared to a placebo-control
[2].Theseclinicaltrialresultshaveraisednumerousquestionsabout
how to optimize public health benefits of this strategy in real-world
settings, such as how to increase PrEP adherence and cost
effectiveness and prevent risk compensation, toxicities, and the
emergence of drug resistance [3]. Though the role of oral PrEP in
preventionefforts may evolve as new data emerge, a prerequisite for
any degree of implementation will be identifying and engaging
individuals who are most likely to benefit from PrEP use [4].
Several years before publication of the iPrEx results, conve-
nience surveys at gay pride events in several United States cities
suggested PrEP awareness (25%) and use (5%) among MSM were
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33119relatively low [5]. Subsequent cross-sectional surveys of MSM in
California and New England corroborated that PrEP awareness
was modest (16–19%) and experience was rare (,1%) [6,7],
though the men were amenable to consider using it if PrEP was
shown to be efficacious (67–74%) [6,7]. Because FTC-TDF is
FDA-approved, this high degree of hypothetical interest suggested
that it was feasible that a rapid increase in MSM demand for oral
PrEP could occur after release of efficacy data. To prepare for this,
the U.S. Centers for Disease Control and Prevention issued an
interim guidance on PrEP for MSM within two months of the
publication of the iPrEx results [8]. However, the actual impact of
these findings for MSM has been unclear.
To assess for changes in PrEP awareness, interest, and use after
the release of efficacy results, repeated cross-sectional, national,
online surveys of MSM using an internet social networking site
were administered two months before and one month after the
publication of iPrEx results. In addition, demographic and
behavioral factors associated with PrEP awareness, interest, and
experience post-iPrEx were determined to identify subgroups that
may be potential targets for educational interventions. As a
substantial proportion of MSM seek sexual partners online [9,10],
and MSM who engage in online sexual networking may be at high
risk for HIV acquisition [11,12,13,14], surveys were administered
through a popular sexual partner-seeking/social networking
website for MSM. Since online sites could provide an attractive
avenue for disseminating information about PrEP [10,15], it was
particularly important to study community norms in this setting.
Methods
Ethics Statement
The Institutional Review Boards of The Fenway Institute and
Beth Israel Deaconess Medical Center approved the study
procedures. All participants provided internet-based informed
consent. As all data were analyzed anonymously, documentation
of written informed consent was waived by these Institutional
Review Boards.
Participants and Procedures
Members of a large, multinational social networking site for
MSM were invited to complete an anonymous online survey about
PrEP knowledge, interest and experience before (September–
October, 2010) and after (December–January, 2011) the release of
iPrEx trial data. At the start of the computer interview, a general
description of PrEP was provided to pre- and post-iPrEx groups.
After this description, data were collected on PrEP awareness,
interest, and experience. For the purpose of these analyses, iPrEx
results were not provided, since the goal was to capture an
unbiased assessment of community norms after public reporting of
iPrEx. Pre-iPrEx, the survey contained 74 items and required
approximately 15–20 minutes to complete. Post-iPrEx, 11 addi-
tional items (not included in the current analyses) were added to
the end of the survey, extending the survey by approximately
4 minutes. Participants were eligible if they were biologically male
at birth, at least 18 years of age, HIV-uninfected by self-report,
and could read and understand English and use computers and the
Internet.
Pre-iPrEx, an email broadcast was sent to the most active
United States members (n=20 000) with an invitation to learn
about the study: 13 284 received and opened the emails, 1 790
(13.5%) clicked through to the survey, 581 (32.5%) consented to
complete a pre-screening questionnaire, 473 (81.4%) met eligibility
criteria, and 398 (84.1%) consented to enroll in the study and have
their data analyzed, representing a 22.2% response rate of those
who clicked on the hyperlink for the study; 134 (33.7%) of
participants abandoned the study before completion. Post-iPrEx,
another email broadcast was sent with an invitation to learn about
the study, and the number of members targeted was increased to
include all U.S. members (excluding those with self-disclosed HIV
infection) given modest enrollment rates from the pre-iPrEx phase:
93 972 members received and opened the emails, 16 715 (17.8%)
clicked through to the survey, 6 267 (37.5%) consented to
complete a pre-screening questionnaire, 5 399 (86.1%) met
eligibility criteria, and 4 558 (84.4%) consented to enroll in the
study and have their data analyzed, representing a 27.3% response
rate; 1 584 (34.8%) of participants abandoned the study before
completion. For participants who did not complete the full survey,
data were analyzed for all questions that were answered. As such,
the total number of respondents is given for each of the measures
reported. Thirty-seven U.S. states and the District of Columbia
were represented pre-iPrEx, and all 50 states and the District of
Columbia were represented post-iPrEx.
Measures
Demographics. Participants reported information on
demographics and history of sexual partnerships [16].
Psychosocial Factors. To screen for alcoholism, the 4-item
CAGE questionnaire was administered [17,18,19]. A score of $10
on the 10-item version of the Centers for Epidemiologic Studies
Depression (CES-D) scale, a validated survey to assess for
depressive symptoms, was considered a positive screen for
depression [20].
Sexual Risk. Data were collected on prior sexually
transmitted infections (STI) and high-risk sexual behaviors,
including recreational substance use during sex and unprotected
anal intercourse with multiple partners or partners who are
reportedly HIV-infected or of unknown HIV serostatus.
Self-Perceived Risk of HIV Acquisition. Participants rated
their risk on a scale of 1 (‘‘Not risky at all’’) to 10 (‘‘Extremely
risky’’) based on their sexual behaviors in the prior 3 months
[21,22].
Engagement in Healthcare. Participants were asked if they
had visited a healthcare provider in the prior 12 months and
whether they identified a primary care provider (PCP) [23].
Communication with Providers. To assess communication
about HIV risk behaviors, participants were asked to indicate their
level of comfort discussing same-sex behaviors with a PCP on a 5-
point scale from 1 (‘‘Extremely uncomfortable’’) to 5 (‘‘Extremely
comfortable’’); responses were dichotomized for analyses such that
a rating of #3 was categorized as ‘‘Not comfortable’’ and $4 was
‘‘Comfortable’’ to provide a conservative estimate of comfort
levels. Participants were also asked if they had discussed
unprotected anal sex behaviors or ways to protect themselves
against HIV infection with a PCP, based on a prior study focused
on patient-provider communication among MSM [23].
Post-Exposure Prophylaxis (PEP). Participants were asked
about their awareness and experience with PEP based on
questions employed in previous studies conducted at the Fenway
Institute [7,24].
PrEP Awareness, Interest, and Experience. Data were
collected on PrEP awareness, interest, and experience using
questions adapted from a prior study of PrEP attitudes among
MSM [7].
Data Analyses
OpenEpi (Atlanta, GA) [25] was used to perform t-tests and x
2
tests of independence, and SAS version 9.2 (Cary, NC) was used
for descriptive statistics and logistic regression modeling. Tests
PrEP Awareness, Interest, and Use among MSM
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independence of respondents contributing to pre- and post-iPrEx
samples was presumed given the large difference in sample sizes.
Because data were obtained using different recruitment methods
for each sample, descriptive analyses were used instead of formal
statistical testing to compare pre- and post-iPrEx results. The
characteristics of participants who completed the survey pre- and
post-iPrEx were stratified by awareness of PrEP. To determine the
relationship between participant characteristics and outcomes of
interest, bivariate logistic regression procedures were conducted.
Variables significant at P,0.05 were included in three distinct
multivariable models to determine factors that were independently
associated with PrEP awareness, interest, and experience. Multi-
collinearity was assessed among independent variables. None of
the independent variables were found to be intercorrelated at or
above a threshold of 0.80 and all were retained in the final models.
Regression procedures were conducted only on post-iPrEx data, as
the substantially larger sample size was more likely to result in
meaningful analyses.
Results
Participant Sociodemographic and Behavioral
Characteristics
Demographics of MSM who participated in the study pre- and
post-iPrEx are presented in Table 1. The majority of participants
pre- and post-iPrEx were white, highly educated, and employed
full-time, with over one-third of MSM reporting annual income of
$60 000 or more. Nearly all men self-identified as gay or bisexual
(.99%). About a quarter of the men had a clinical history of
depression and almost 1/5 screened in for depression when they
filled out the survey. Prior drug or alcohol treatment, and current
alcohol abuse, were also common (Table 1). Over half of the pre-
iPrEx participants reported unprotected anal intercourse (UAI)
with at least one male partner of any HIV serostatus in the 3
months prior to completing the survey, and approximately one-
quarter reported UAI with at least one male partner of reportedly
HIV-positive or unknown serostatus or a history of STI. The men
who filled out the survey post-iPrEx were comparably risky, but a
smaller percentage of the respondents indicated they had engaged
in UAI while using recreational drugs. Most participants perceived
themselves to be at low to moderate risk to acquire HIV. Overall,
no clinically meaningful differences in participant sociodemo-
graphic and behavioral characteristics were apparent between the
samples.
Engagement in Healthcare, Communication with
Providers, and Post-Exposure Prophylaxis Experience
Most participants reported contact with a healthcare provider in
the prior 12 months and identified a primary care provider
(Table 1). Less than half of MSM had discussed ways to protect
against HIV with a PCP. Although approximately one-third of
participants were aware of PEP in each group, prior use was
uncommon (Table 1).
PrEP Awareness and Interest
Awareness of PrEP was limited but increased after iPrEx (12.5%
(36/289) pre-iPrEx vs. 19.0% (642/3387) post-iPrEx). Fewer
participants of moderate income ($18 000–$29 000 per year) were
aware of PrEP after iPrEx (25.0% pre-iPrEx vs. 10.5% post-
iPrEx). Otherwise, MSM who were aware of PrEP pre- and post-
iPrEx did not appear to differ sociodemographically or behavior-
ally. Pre- and post-iPrEx, the majority of the participants
expressed interest in using PrEP after they were provided with a
brief description about it (76.1% (220/289) pre-iPrEx vs. 78.5%
(2654/3382) post-iPrEx).
In multivariable analysis, being aware of PrEP was associated
with identifying as bisexual compared to gay (OR 1.87; 1.01–3.46;
p=0.05), awareness of PEP versus no awareness (OR 33.7; CI
21.3–53.3; p,0.0001), and prior PEP use compared to never
having used PEP (OR 1.97; CI 1.15–3.38; p=0.01) (Table 2).
In a separate multivariable model, interest in PrEP use was
associated with being older (OR 1.01; CI 1.00–1.02; p=0.01),
having greater self-perceived risk of HIV acquisition (OR 1.20; CI
1.13–1.27; p,0.0001), and UAI with at least 1 male partner in the
prior 3 months versus no UAI in the prior 3 months (OR 1.41; CI
1.11–1.79; p=0.004); awareness of PEP, compared to no
knowledge of PEP, was associated with decreased interest in using
PrEP (OR 0.55; CI 0.43–0.71; p,0.0001) (Table 3).
PrEP Experience
Pre-iPrEx, 0.7% (2/289) of respondents reported having used
PrEP, whereas post-iPrEx, 0.9% (29/3385) did. The sources of
PrEP for the 29 individuals who reported prior PrEP use included:
their PCP (8); another healthcare provider (8); a friend (6); the
internet (1); a sex partner (2); and ‘‘Other’’ (8) without further
details. Three respondents indicated participation in a clinical trial
of PrEP. Eighty-percent (20/25) reported using PrEP on a daily
basis for a period of time, while the others used PrEP only right
before sex. Compared to MSM who had not used PrEP, a greater
percentage of those with PrEP experience reported UAI with at
least one male partner, and had at least 5 male partners in the
prior 3 months. PrEP users were more likely to know about, and
have used, PEP and to have engaged in discussions with a PCP
about ways to protect themselves against HIV (Table 4).
In multivariable analysis, PrEP users were at greater odds of
having had sex with men and women compared to sex with men
only (OR 4.76; CI 1.40–16.2; p=0.01), having had UAI with at
least one male partner in the prior 3 months versus no UAI (OR
3.62; CI 1.00–13.1; p=0.05), being aware of PEP compared to
not being aware (OR 7.46; CI 1.52–36.6; p=0.01), and being PEP
experienced (OR 34.2; CI 13.3–88.4; p,0.0001) (Table 5).
Discussion
The successful demonstration of PrEP efficacy [2] may offer a
new way to curtail the increasing number of new HIV infections
among MSM in the U.S. [1] and around the world [26,27].
Increasingly, MSM are meeting partners and obtaining health
information through the internet [15,28,29]. The current study of
MSM engaged in online social networking showed that there was
an increase in PrEP awareness among a sample interviewed after
the publication of the iPrEx results compared with a sample
interviewed before iPrEx. Although the current study demonstrat-
ed that knowledge of PrEP immediately after iPrEx was limited
overall (19%), this is not surprising as the diffusion of new
knowledge clearly takes time. However, once chemoprophylaxis
was described to the men, interest in PrEP use was high.
The majority of the men sampled on this online sexual network
were highly educated and affluent; these demographic character-
istics are consistent with those that have been previously associated
with increased PrEP awareness [7]. These men are likely to
represent a relatively knowledgeable subset of U.S. MSM
regarding new prevention findings, so studies to assess PrEP
awareness among representative samples of MSM are still needed.
In this study, men who were not familiar with PEP and those who
only had male partners were less likely to know about PrEP, so
strategies to increase PrEP uptake for this population of MSM will
PrEP Awareness, Interest, and Use among MSM
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after (n=4 558) Publication of Oral Pre-Exposure Prophylaxis Efficacy Results (the iPrEx Study).
Pre-iPrEx (N=398) Post-iPrEx (N=4558)
Mean (SD) N
1 Mean (SD) N
1
Age 40.2 (12.1) 398 39.0 (12.8) 4558
Number of male partners (UAI) in prior 3 mo. 2.4 (5.5) 395 2.1 (5.3) 4558
Self-perceived risk of HIV acquisition
2 3.6 (2.4) 288 3.3 (2.3) 3739
%%
Pre-Exposure Prophylaxis (PrEP) Aware of PrEP 12.5 289 19.0 3387
Interested in using PrEP
3 76.1 289 78.5 3382
Have used PrEP 0.7 289 0.9 3385
Sexual Orientation
4 Homosexual or Gay 88.8 268 83.2 2977
Bisexual 11.2 268 16.3 2977
Gender of Sex Partners - prior 3 mo. Men Only 95.9 291 92.6 3401
Men and Women 4.1 291 7.4 3401
Race/Ethnicity Asian/Asian American/Pacific Islander 6.0 268 2.7 3003
Hispanic/Latino 7.1 268 5.9 3003
African American/Black 2.2 268 3.2 3003
White 82.1 268 84.0 3003
Native American/Alaskan Native 0.4 268 0.6 3003
Multiracial/Other 2.2 268 3.6 3003
Education # High school/GED 6.4 266 6.6 3003
Some College - College graduate 59.8 266 56.7 3003
$ Some Graduate training 32.8 266 36.8 3003
Employment Full-Time ($30 hrs./wk.) 63.3 267 67.0 3001
, Full-time, Student, Other 36.7 267 33.0 3001
Annual Income (Pre-tax) #$17,999 16.7 263 18.5 2958
$18,000–$29,999 16.3 263 13.0 2958
$30,000–$59,999 25.5 263 29.4 2958
$$60,000 41.4 263 39.1 2958
Health Insurance - Covered 83.1 255 85.8 2892
High-Risk Sex - prior 3 mo. UAI with $1 male partner 58.4 397 61.8 4558
UAI with $5 male partners 12.2 395 10.4 4558
UAI with $1 HIV-infected or unknown serostatus male partner 24.2 393 23.4 4555
Transactional sex 6.2 292 7.3 3469
UAI after $5 drinks 24.3 263 23.0 2975
UAI while using recreational drugs 18.6 264 10.9 2974
Prior STI 27.7 398 28.0 4558
Post-Exposure Prophylaxis (PEP) Heard of PEP 38.1 289 36.2 3396
Used PEP 4.5 289 3.7 3394
Engagement in Healthcare Contact w/any provider - prior 12 mo. 85.9 269 89.1 3113
Identifies a PCP 76.6 269 81.8 3113
Communication with PCP PCP aware of UAI behaviors
5 47.5 143 38.2 1666
Comfortable discussing same-sex behaviors w/PCP 68.8 205 61.5 2537
Discussed ways to protect against HIV w/PCP 47.8 205 43.7 2536
Psychosocial Factors History of depression 24.7 267 25.3 2988
Positive screen - depression (CES-D) 31.9 263 25.5 2956
PrEP Awareness, Interest, and Use among MSM
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who were older, who reported recent UAI with a man and/or
perceived themselves to be at increased risk of HIV acquisition
more often indicated interest in using PrEP. This suggests that
some MSM who may benefit from PrEP might be open to using it
as a protective intervention. In this group, efforts should be
focused on facilitating access to healthcare providers who can help
individuals make informed decisions regarding PrEP use. For
MSM who are younger, as well as those who may misperceive or
deny their risks, education regarding risk assessment should be
stressed as this will not only increase identification of those MSM
who may benefit from PrEP, but could also increase utilization of
HIV and STI testing.
MSM who reported prior knowledge of PEP were at 30-fold
greater odds of having heard about PrEP but at nearly half the
odds of expressing interest in using it, yet MSM who had used PEP
were more likely to report PrEP use. A possible explanation for this
paradox is that MSM who had heard about PEP, but had not used
it, may have concerns about chemoprophylaxis in general,
whereas those who had actually used PEP were more willing to
try a similar intervention. Further studies to understand how
perceptions and experiences with PEP affect attitudes and
decisions regarding PrEP are needed.
The current study found minimal evidence of immediate
uptake of PrEP in this community despite the fact that a majority
of MSM were interested in using PrEP. It is understandable that
there was limited PrEP use given the fact that the iPrEx results
were released only a month prior to the second survey and
implementation of medical innovations do not occur in that time
frame. However, this study suggests that additional impediments
to PrEP uptake may exist, as nearly 1 in 5 MSM surveyed in this
study had heard of PrEP, but less than 1 in 100 had taken it.
Unclear payment mechanisms could be among these barriers
given estimated costs of PrEP use of $10 000 per person annually
[30]. Issues related to patient-provider communication could
also limit PrEP provision, as a substantial proportion of at-risk
MSM in this study had not discussed risky sexual behaviors or
ways to protect against HIV acquisition with a primary care
provider. Therefore, it is important to improve training of
providers so they become comfortable discussing MSM sexuality
in an effort to identify MSM who would be most likely to benefit
from PrEP. Clinicians may also be cautious about prescribing
PrEP due to concerns regarding potential unintended conse-
Table 1. Cont.
Pre-iPrEx (N=398) Post-iPrEx (N=4558)
Mean (SD) N
1 Mean (SD) N
1
Ever treated for drug or alcohol abuse 3.4 263 4.8 2970
Positive screen - alcohol abuse (CAGE) 18.4 261 16.3 2965
UAI=unprotected anal intercourse; STI=sexually transmitted infection; PCP=primary care provider; CES-D=Center for Epidemiologic Studies Depression Scale;
CAGE=4-question screen for alcohol abuse.
1Total number of participants responding to each question.
2Self-perceived risk of HIV acquisition=scale from 1 (no risk) to 10 (extreme risk).
3Interested in using PrEP=likely or extremely likely to use PrEP.
4Excludes 15/2977 (0.5%) participants who self-identified as heterosexual post-iPrEx.
5Among participants indicating UAI in the prior 3 months.
doi:10.1371/journal.pone.0033119.t001
Table 2. Participant Characteristics associated with Awareness of Pre-Exposure Prophylaxis (n=642) One Month after Publication
of Efficacy Results (the iPrEx Study).
Aware of PrEP
Bivariate OR 95% CI P Multivariable OR 95% CI P
Sexual Orientation Homosexual or Gay 1.00 - - 1.00 - -
Bisexual 0.50 0.37–0.67 ,0.0001 1.87 1.01–3.46 0.05
Post-exposure Prophylaxis (PEP) Aware of PEP 38.4 28.5–51.8 ,0.0001 33.7 21.3–53.3 ,0.0001
Not aware of PEP 1.00 - - 1.00 - -
Prior PEP use 5.21 3.63–7.49 ,0.0001 1.97 1.15–3.38 0.01
No prior PEP use 1.00 - - 1.00 - -
PrEP=pre-exposure prophylaxis; OR=odds ratio; CI=Confidence Interval; P=level of significance.
Variables that were not statistically significant in bivariate analyses and were not entered into the multivariable model include: number of male partners for unprotected
anal intercourse (UAI) in the prior 3 months; self-perceived risk of HIV acquisition; monogamous status; race/ethnicity; health insurance coverage; UAI with $1 male
partner, UAI with $5 male partners, UAI with $1 male partner who is HIV-infected or of unknown serostatus, transactional sex, UAI after $5 drinks, and UAI while using
recreational drugs, each over the prior 3 months; identification of a primary care provider; diagnostic history of clinical depression; positive screen for depressive
symptoms (Center for Epidemiologic Studies Scale); and prior treatment for drug or alcohol abuse. Variables that were not statistically significant in multivariable
analyses include: interest in PrEP (likely or extremely likely to use PrEP); gender of sexual partners in prior 3 months; educational attainment; employment status; annual
income; history of sexually transmitted infection; contact with any healthcare provider in the prior 12 months; among participants indicating UAI in the prior 3 months,
having a primary care provider (PCP) who is aware of UAI behaviors; comfort discussing same-sex behaviors with PCP; having discussed ways to protect against HIV
acquisition with PCP; and positive screen for alcohol abuse (4-item CAGE questionnaire).
doi:10.1371/journal.pone.0033119.t002
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[31], or development of drug resistance [32]. A cross-sectional
survey of generalist physicians and HIV specialists in Massa-
chusetts showed that after iPrEx, nearly all providers (92%) were
aware of oral PrEP and most (76%) would be willing to prescribe
it to high-risk MSM based on the results of the iPrEx study,
though data to suggest the aforementioned consequences could
dissuade them [Mayer et al., unpublished data]. It will be
important to provide physicians with accurate data on the risks
and benefits of PrEP and tools to help them communicate this
information to MSM so they can share in evidence-based
decision making regarding PrEP prescribing. Further studies are
needed to understand facilitators and barriers to implementing
this new intervention.
This study has several limitations. The most notable is that
data was drawn from two different samples, using two different
recruitment methods (i.e., inviting the most active users pre-
i P r E xv e r s u sa l lm e m b e r so ft h i sn etwork post-iPrEx), resulting
in different sample sizes. As such, the observed increase in PrEP
awareness could potentially refle c ts a m p l i n gd i f f e r e n c e sa n dn o t
a true increase in knowledge. However, the study samples were
similar with respect to variables that have previously been
associated with greater PrEP awareness, such as level of PEP
knowledge, education and income [7], so a bias towards
increased awareness post-iPrEx is unlikely. Additional limita-
tions suggest that participants are not representative of at-risk
MSM in general. First, while the number of participants in this
study was high, there was a low response rate overall (22.2%
pre-iPrEx and 27.3% post-iPrEx). Other studies utilizing
internet recruitment of MSM have reported rates of participa-
tion ranging from 5%–61% [33,34,35,36]. Reassuringly, partic-
ipant demographics in this study sample were comparable to
those found in other recent studies involving members of the
same online network [37,38], making it more likely that the
study sample accurately represents the network’s demographics.
Second, study completion rates were modest with only two-
thirds of participants responding to all survey questions.
However, the pattern of missing data was most consistent with
non-completion of surveys because of fatigue [39], and would
therefore be unlikely to bias the results of the PrEP-related
outcomes asked early in the survey. Third, participants were
recruited online. Yet this limitation also provides a strength in
that previous studies have demonstrated that online data
collection has the potential to limit social desirability bias and
result in more honest and accurate responses [40,41]. Finally,
the mean age of participants was 40 years and .80% were
white, so they are not representative of some of the highest risk
groups, such as young black and Latino/Hispanic MSM [1].
However, nearly 40% of new infections among U.S. MSM occur
in whites [1], so the study findings are likely to be relevant for a
substantial population of at-risk MSM.
The findings of modest awareness, substantial interest, and
minimal use of PrEP among MSM using a popular social
networking website immediately after publication of iPrEx
results suggests that informational campaigns are needed to
raise awareness of PrEP and facilitate dialogues among at-risk
MSM and their providers. As the internet may provide an
effective means for disseminating risk reduction campaigns
among at-risk MSM [42,43,44], web-based informational
programs about PrEP that are targeted to this population are
warranted. In addition, prospective studies are needed to
understand MSM- and provider-related barriers to discussing
HIV risk behaviors and initiating PrEP in the clinical setting. As
efforts continue to focus on the use of biomedical interventions
for HIV prevention, translation of PrEP interest into effective
use of chemoprophylaxis remains a priority among strategies to
decrease the rate of new HIV infections among high-risk
populations.
Table 3. Participant Characteristics associated with Interest in Using Pre-Exposure Prophylaxis (n=2 654) One Month after
Publication of Efficacy Results (the iPrEx Study).
Interested in Using PrEP
1
Bivariate OR 95% CI P
Multivariable
OR 95% CI P
Age 1.01 1.01–1.02 0.0002 1.01 1.00–1.02 0.01
Self-perceived risk of HIV acquisition
2 1.20 1.15–1.25 ,0.0001 1.20 1.13–1.27 ,0.0001
High-Risk Sex - prior 3 mo. UAI with $1 male partner 1.72 1.45–2.03 ,0.0001 1.41 1.11–1.79 0.004
No UAI with male partner 1.00 - - 1.00 - -
Post-Exposure Prophylaxis (PEP) Aware of PEP 0.51 0.44–0.61 ,0.0001 0.55 0.43–0.71 ,0.0001
Not aware of PEP 1.00 - - 1.00 - -
PrEP=pre-exposure prophylaxis; OR=odds ratio; CI=Confidence Interval; P=level of significance; UAI=unprotected anal intercourse.
1Interested in Using PrEP=likely or extremely likely to use PrEP.
2Self-perceived risk of HIV acquisition=scale from 1 (no risk) to 10 (extreme risk).
Variables that were not statistically significant in bivariate analyses and were not entered into the multivariable model include: monogamous status; race/ethnicity;
employment status; annual income; health insurance coverage; transactional sex, UAI after $5 drinks and UAI while using recreational drugs - each over the prior 3
months; history of sexually transmitted infection; prior PEP use; contact with any healthcare provider in prior 12 months; identification of a primary care provider (PCP);
among participants indicating UAI in prior 3 months, having a PCP who is aware of UAI behaviors; diagnostic history of clinical depression; positive screen for depressive
symptoms (Center for Epidemiologic Studies Scale); and prior treatment for drug or alcohol abuse. Variables that were not statistically significant in multivariable
analyses include: number of male partners for UAI in the prior 3 months; awareness of PrEP; sexual orientation; gender of sexual partners in prior 3 months; educational
attainment; UAI with $5 male partners and UAI with $1 male partner who is HIV-infected or of unknown serostatus - each over the prior 3 months; comfort discussing
same-sex behaviors with PCP; having discussed ways to protect against HIV acquisition with PCP; and positive screen for alcohol abuse (4-item CAGE questionnaire).
doi:10.1371/journal.pone.0033119.t003
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Have used PrEP (n=29) Have not used PrEP (n=3356)
Mean (SD) N
1 Mean (SD) N
1
Age 41.2 (11.3) 29 39.7 (12.8) 3356
Number of male partners (UAI) - prior 3 mo. 4.7 (9.4) 29 2.3 (5.0) 3356
Self-perceived risk of HIV acquisition
2 4.0 (2.2) 29 3.3 (2.3) 3353
%%
Pre-Exposure Prophylaxis (PrEP) Interested in using PrEP
3 77.8 27 78.5 3354
Sexual Orientation Homosexual or Gay 69.6 23 83.7 2937
Bisexual 30.4 23 16.3 2937
Gender of Sex Partners - prior 3 mo. Men only 82.1 28 92.7 3286
Men and Women 17.9 28 7.3 3286
Race/Ethnicity White 78.3 23 84.1 2978
Other 21.7 23 15.9 2978
Education # High school/GED 4.4 23 6.6 2978
Some college - College graduate 52.2 23 56.7 2978
$ Some graduate training 43.5 23 36.7 2978
Employment Full-time ($30 hrs./wk.) 65.2 23 67.0 2976
, Full-time, Student, Other 34.8 23 33.0 2976
Annual Income (Pre-tax) #$17,999 21.7 23 18.5 2933
$18,000–$29,999 13.0 23 13.1 2933
$30,000–$59,999 21.7 23 29.4 2933
$$60,000 43.5 23 39.0 2933
Health Insurance – Covered 95.5 22 85.7 2868
High-Risk Sex - prior 3 mo. UAI with $1 male partner 86.2 29 66.1 3356 *
UAI with $5 male partners 24.1 29 11.9 3356 **
UAI with $1 HIV-infected or unknown
serostatus male partner
34.5 29 27.5 3356
Transactional sex 13.8 29 7.3 3352
UAI after $5 drinks 26.1 23 23.0 2951
UAI while using recreational drugs 17.4 23 10.9 2950
Prior STI 31.0 29 29.3 3356
Post-Exposure Prophylaxis (PEP) Heard of PEP 89.7 29 35.7 3356 **
Used PEP 69.0 29 3.1 3354 **
Engagement in Healthcare Contact w/any provider - prior 12 mo. 95.8 24 89.1 3087
Identifies a PCP 75.0 24 81.8 3087
Communication with PCP PCP aware of UAI behaviors
4 58.8 17 38.0 1648
Comfortable discussing same-sex behaviors w/
PCP
83.3 18 61.3 2517
Discussed ways to protect against HIV w/PCP 66.7 18 43.6 2516 *
Psychosocial Factors History of depression 21.7 23 25.3 2963
Positive screen - depression (CES-D) 22.7 22 25.5 2933
Ever treated for drug or alcohol abuse 0 23 4.9 2946
Positive screen - alcohol abuse (CAGE) 4.4 23 16.4 2941
UAI=unprotected anal intercourse; STI=sexually transmitted infection; PCP=primary care provider; CES-D=Center for Epidemiologic Studies Depression Scale;
CAGE=4-question screen for alcohol abuse.
*P#0.05,
**P#0.01 using test for difference between groups: t-test for continuous variables, chi-squared test or Fisher’s exact test (when cell sizes are small) for categorical
variables.
1Total number of participants responding to each question.
2Self-perceived risk of HIV acquisition=scale from 1 (no risk) to 10 (extreme risk).
3Interested in using PrEP=likely or extremely likely to use PrEP.
4Among participants indicating UAI in the prior 3 months.
doi:10.1371/journal.pone.0033119.t004
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